CG
LAB icon

Cutler Group’s Standard BioTools LAB Stock Holding History

Cutler Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,446
Closed -$5K – 5349
2022
Q1 		$5K Hold
1,446
– – ﹤0.01% 4137
2021
Q4 		$5K Sell
1,446
-7,500
-84% -$35.1K ﹤0.01% 4196
2021
Q3 		$58K Buy
+8,946
New +$58.9K ﹤0.01% 2390
2021
Q2 		– Sell
-18,671
Closed -$99.8K – 6047
2021
Q1 		$84K Buy
18,671
+5,302
+40% +$29.1K ﹤0.01% 1910
2020
Q4 		$80K Sell
13,369
-44,538
-77% -$293K ﹤0.01% 1674
2020
Q3 		$430K Buy
+57,907
New +$400K 0.03% 584
2017
Q4 		– Sell
-4,671
Closed -$23K – 5430
2017
Q3 		$23K Buy
4,671
+1,299
+39% +$5.46K ﹤0.01% 3007
2017
Q2 		$13K Sell
3,372
-3,819
-53% -$18.1K ﹤0.01% 3891
2017
Q1 		$40K Sell
7,191
-2,640
-27% -$16.7K ﹤0.01% 2622
2016
Q4 		$71K Buy
9,831
+2,399
+32% +$15.1K ﹤0.01% 2221
2016
Q3 		$59K Buy
7,432
+433
+6% +$3.98K ﹤0.01% 2298
2016
Q2 		$63K Buy
6,999
+155
+2% +$1.46K ﹤0.01% 2128
2016
Q1 		$55K Sell
6,844
-7,156
-51% -$51.6K ﹤0.01% 2218
2015
Q4 		$151K Buy
+14,000
New +$137K 0.01% 1406

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's LAB Position: Q2 2022 in Review

Cutler Group sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 1,446 shares — an estimated $5K sold.

Cutler Group first reported a position in LAB in Q4 2015 and held it in 14 quarters. The position peaked at $430K in Q3 2020. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • Cutler Group reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 1,446 Standard BioTools shares in Q2 2022, an estimated $5K.
  • Cutler Group first reported a position in Standard BioTools in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Standard BioTools position peaked at $430K in Q3 2020.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.